Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Account Payables (2017 - 2025)

Neuronetics (STIM) has disclosed Change in Account Payables for 9 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables rose 353.82% to $1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$538000.0, a 219.29% decrease, with the full-year FY2024 number at -$2.0 million, down 197.83% from a year prior.
  • Change in Account Payables was $1.7 million for Q3 2025 at Neuronetics, up from $835000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.5 million in Q1 2023 to a low of -$2.6 million in Q1 2025.
  • A 5-year average of -$90789.5 and a median of -$30000.0 in 2022 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 754.98% in 2023; the steepest drop was 2923.33% in 2023.
  • Neuronetics' Change in Account Payables stood at $1.1 million in 2021, then plummeted by 79.3% to $231000.0 in 2022, then skyrocketed by 754.98% to $2.0 million in 2023, then tumbled by 123.34% to -$461000.0 in 2024, then skyrocketed by 474.4% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Change in Account Payables are $1.7 million (Q3 2025), $835000.0 (Q2 2025), and -$2.6 million (Q1 2025).